Official financial segments often reflect bureaucracy, not true business economics. By creating a 'Shadow P&L' through deductive analysis, investors can uncover massive hidden costs in non-core initiatives, as ValueAct did with Microsoft's hardware divisions.
Related Insights
Activists can be effective even in companies with dual-class shares or founder control. The mechanism for influence is not the threat of a proxy fight but the power of good ideas and relationships to achieve strategic alignment with the controlling party.
Strong, cash-rich businesses often become unfocused and bloated, tolerating poor decisions that would bankrupt lesser firms. ValueAct Capital calls this the 'disease of abundance,' which they aim to cure by refocusing management on core strengths.
A significant portion of biotech's high costs stems from its "artisanal" nature, where each company develops bespoke digital workflows and data structures. This inefficiency arises because startups are often structured for acquisition after a single clinical success, not for long-term, scalable operations.
Microsoft's earnings report revealed a $3.1 billion quarterly loss from its 27% OpenAI stake, implying OpenAI's total losses could approach $40-50 billion annually. This massive cash burn underscores the extreme cost of frontier AI development and the immense pressure to generate revenue ahead of a potential IPO.
Historically, labor costs dwarfed software spending. As AI automates tasks, software budgets will balloon, turning into a primary corporate expense. This forces CFOs to scrutinize software ROI with the same rigor they once applied only to their workforce.
Create AI agents that embody key executive personas to monitor operations. A 'CFO agent' could audit for cost efficiency while a 'brand agent' checks for compliance. This system surfaces strategic conflicts that require a human-in-the-loop to arbitrate, ensuring alignment.
Beyond budget expenses, intense political engagement consumes significant managerial time and energy. This focus on navigating policy and lobbying efforts directly detracts from resources that were previously dedicated to product innovation, customer service, and operational efficiency.
A common activist trap is 'ambulance chasing'—looking for problems to fix. ValueAct argues the correct sequence is to first identify a great company with a differentiated investment thesis. The need for influence is secondary, preventing adverse selection.
Major technological shifts create new industries in unpredictable ways. The spreadsheet automated manual financial modeling, revealing massive inefficiencies in companies. This enabled private equity firms to acquire businesses, streamline operations using this new tool, and extract value, effectively birthing the modern PE industry.
Beyond outright fraud, startups often misrepresent financial health in subtle ways. Common examples include classifying trial revenue as ARR or recognizing contracts that have "out for convenience" clauses. These gray-area distinctions can drastically inflate a company's perceived stability and mislead investors.
